Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of biologically active molecules targeting central nervous system disorders and metabolic diseases. Its structure supports the construction of peptidomimetics and enzyme inhibitors, where the difluoropyrrolidine moiety enhances metabolic stability and bioavailability. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its conformational rigidity and fluorine-induced electronic effects.